Targeted use of vancomycin as perioperative prophylaxis reduces periprosthetic joint infection in revision TKA knee

Clinical Orthopaedics and Related Research

Volumn 472, Issue 1, 2014, Pages 227-231

  Liu, Catherine ^a   Kakis, Anthony ^b   Nichols, Amy ^b   Ries, Michael D ^b   Vail, Thomas P ^b   Bozic, Kevin J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; CONFERENCE PAPER; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS EPIDERMIS; MINIMUM INHIBITORY CONCENTRATION; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PERIPROSTHETIC JOINT INFECTION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; RISK REDUCTION; SINGLE DRUG DOSE; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION; TOTAL KNEE REPLACEMENT; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 84891749101     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-013-3029-0     Document Type: Conference Paper

References (17)

1. American Academy of Orthopaedic Surgeons (AAOS). Recommendations for the use of intravenous antibiotic prophylaxis in primary total joint arthroplasty. Available at: http://www.aaos.org/about/papers/advistmt/1027.asp. Accessed December 10, 2012.
2. Anderson DJ, Kaye KS, Classen D, Arias KM, Podgorny K, Burstin H, Calfee DP, Coffin SE, Dubberke ER, Fraser V, Gerding DN, Griffin FA, Gross P, Klompas M, Lo E, Marschall J, Mermel LA, Nicolle L, Pegues DA, Perl TM, Saint S, Salgado CD, Weinstein RA, Wise R, Yokoe DS. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(Suppl 1): S51-61.
3. Bolon MK, Morlote M, Weber SG, Koplan B, Carmeli Y, Wright SB. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis. 2004;38:1357-1363.
4. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38:1706-1715.
5. Centers for Disease Control and Prevention (CDC). Surgical site infection (SSI) event 2011. Available at: http://www.cdc.gov/nhsn/PDFs/pscManual/ 9pscSSIcurrent.pdf. Accessed December 10, 2011.
6. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23:984-991.
7. Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty. 2012;27:61-65.e61.
8. Mortazavi SM, Schwartzenberger J, Austin MS, Purtill JJ, Parvizi J. Revision total knee arthroplasty infection: incidence and predictors. Clin Orthop Relat Res. 2010;468:2052-2059.
9. Poss R, Thornhill TS, Ewald FC, Thomas WH, Batte NJ, Sledge CB. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res. 1984;182:117-126.
10. Ritter MA, Barzilauskas CD, Faris PM, Keating EM. Vancomycin prophylaxis and elective total joint arthroplasty. Orthopedics. 1989;12:1333-1336.
11. Savarese A, Nanni ML, Pasquali C, Egidio AC. Vancomycin prophylaxis in joint arthroplasty. Chir Organi Mov. 1999;84:247-251.
12. Sculco TP. The economic impact of infected joint arthroplasty. Orthopedics. 1995;18:871-873.
13. Sewick A, Makani A, Wu C, O'Donnell J, Baldwin KD, Lee GC. Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty? Clin Orthop Relat Res. 2012;470:2702-2707.
14. Sierra RJ, Cooney WP, Pagnano MW, Trousdale RT, Rand JA. Reoperations after 3200 revision TKAs: rates, etiology, and lessons learned. Clin Orthop Relat Res. 2004;425:200-206.
15. Smith EB, Wynne R, Joshi A, Liu H, Good RP. Is it time to include vancomycin for routine perioperative antibiotic prophylaxis in total joint arthroplasty patients? J Arthroplasty. 2012;27:55-60.
16. Song KH, Kang YM, Sin HY, Yoon SW, Seo HK, Kwon S, Shin MJ, Chang CB, Kim TK, Kim HB. Outcome of cefazolin prophylaxis for total knee arthroplasty at an institution with high prevalence of methicillin-resistant Staphylococcus aureus infection. Int J Infect Dis. 2011;15:e867-870.
17. Wymenga AB, van Horn JR, Theeuwes A, Muytjens HL, Slooff TJ. Perioperative factors associated with septic arthritis after arthroplasty. Prospective multicenter study of 362 knee and 2,651 hip operations. Acta Orthop Scand. 1992;63:665-671.